Interestingly, glutamine treatment can ameliorate obesity and related comorbidities in mice (Figure 5), consistent with previous observations that glutamine supplementation reduces obesity with an improvement in systemic insulin action 70,71. The gene discussed is INS; the disease is obesity disorder.